Paid Clinical Trials in Scottsdale, AZ

As of September 2026, 393 paid clinical trials are recruiting in Scottsdale, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

358 clinical trials

Get a weekly email when new trials open in Scottsdale, AZ.

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

for Breast Reconstruction Surgery

Sites in Scottsdale, Tucson +18 more locations

Sponsor: W.L.Gore & Associates

Sex: Female·Age: 22+

Code: NCT06556654·Recruiting·Listed Aug 2024

Apply to this trial

DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

Sites in Scottsdale, Phoenix +11 more locations

Sponsor: DynamiCure Biotechnology

Sex: All·Age: 18+

Code: NCT05785754·Phase 1·Recruiting·Listed Mar 2023

Apply to this trial

CERAMENT™| Bone Void Filler Device Registry

for Orthopedic Disorder

Sites in Scottsdale +10 more locations

Sponsor: BONESUPPORT AB

Sex: All·Age: 18+

Code: NCT04244942·Recruiting·Listed Jan 2020

Apply to this trial

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

for T-cell Lymphoma

Sites in Scottsdale +9 more locations

Sponsor: SciTech Development, Inc.

Sex: All·Age: 18+

Code: NCT04234048·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Serranator POINT FORCE Registry

for Peripheral Artery Disease (PAD)

Sites in Scottsdale +17 more locations

Sponsor: Cagent Vascular LLC

Sex: All·Age: 18+

Code: NCT06687590·Recruiting·Listed Nov 2024

Apply to this trial

Treatment of Moderate to Severe Refractory Crohn's Disease

for Crohns Disease

Sites in Scottsdale +12 more locations

Sponsor: Tr1X, Inc.

Sex: All·Age: 18 - 65

Code: NCT06721962·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

for Idiopathic Pulmonary Fibrosis (IPF)

Sites in Scottsdale +11 more locations

Sponsor: InSilico Medicine Hong Kong Limited

Sex: All·Age: 40+

Code: NCT05975983·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

for Coronary Artery Disease

Sites in Scottsdale, Chandler +15 more locations

Sponsor: Kardion Inc

Sex: All·Age: 18 - 90

Code: NCT06445608·Recruiting·Listed Jun 2024

Apply to this trial

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

for Intestinal Failure Associated Liver Disease

Sites in Scottsdale +12 more locations

Sponsor: NorthSea Therapeutics B.V.

Sex: All·Age: 16+

Code: NCT05919680·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

Sites in Scottsdale +3 more locations

Sponsor: SHY Therapeutics

Sex: All·Age: 18+

Code: NCT07705334·Phase 1·Recruiting·Listed Jul 2026

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

for Advanced Prostate Cancer

Sites in Scottsdale +1 more location

Sponsor: Genentech, Inc.

Sex: Male·Age: 18+

Code: NCT07567846·Phase 1, Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

for Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Drug: NIO752

Sites in Scottsdale +4 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 41 - 81

Code: NCT07498426·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

for Ocular Myasthenia Gravis

Sites in Scottsdale +4 more locations

Sponsor: UCB Biopharma SRL

Sex: All·Age: 18+

Code: NCT07463521·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

for Type-2 Diabetes Mellitus

Sites in Scottsdale +3 more locations

Sponsor: Aqua Medical, Inc.

Sex: All·Age: 22 - 65

Code: NCT07355270·Recruiting·Listed Jan 2026

Apply to this trial

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

for Advanced Solid Tumor, Adult

Sites in Scottsdale +14 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for PIK3CA Mutations

Sites in Scottsdale +10 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07383506·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of TAK-755 in Adults With Acute Ischemic Stroke

for Acute Ischemic Stroke

Sites in Scottsdale, Tucson +7 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07392450·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for Pulmonary Arterial Hypertension

Sites in Scottsdale +14 more locations

Sponsor: Inhibikase Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07365332·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

for Pulmonary Hypertension Due to Lung Disease (Disorder)

Sites in Scottsdale, Phoenix +10 more locations

Sponsor: Liquidia Technologies, Inc.

Sex: All·Age: 18 - 80

Code: NCT07285655·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

for Refractory Melanoma

Sites in Scottsdale, Gilbert +6 more locations

Sponsor: Diakonos Oncology Corporation

Sex: All·Age: 18+

Code: NCT07288112·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Evaluation of the Efficacy and Safety of THRV-1268 in Participants With Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)

for Long QT Syndrome (LQTS) 2

Sites in Scottsdale +8 more locations

Sponsor: Thryv Therapeutics, Inc.

Sex: All·Age: 15+

Code: NCT07277582·Phase 2, Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for Glioblastoma

Sites in Scottsdale +8 more locations

Sponsor: GT Medical Technologies, Inc.

Sex: All·Age: 18+

Code: NCT07195591·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

for Atopic Dermatitis

Sites in Scottsdale +11 more locations

Sponsor: Pfizer

Sex: All·Age: 18 - 64

Code: NCT07216027·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for Advanced Prostate Cancer

Sites in Scottsdale +4 more locations

Sponsor: Genentech, Inc.

Sex: Male·Age: 18+

Code: NCT05800665·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

for Ovarian Neoplasms

Sites in Scottsdale +9 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06400472·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

for Solid Tumor

Sites in Scottsdale +7 more locations

Sponsor: Alyssum Therapeutics

Sex: All·Age: 18+

Code: NCT06234098·Phase 1, Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for Low-grade Upper Tract Urothelial Carcinoma

Drug: Nadofaragene Firadenovec

Sites in Scottsdale +7 more locations

Sponsor: Ferring Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Study of KK2269 in Adult Participants With Solid Tumors

for Advanced Solid Tumor

Sites in Scottsdale +6 more locations

Sponsor: Kyowa Kirin Co., Ltd.

Sex: All·Age: 18+

Code: NCT06266299·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

for Amyotrophic Lateral Sclerosis (ALS)

Sites in Scottsdale +4 more locations

Sponsor: PhenoNet, Inc.

Sex: All·Age: 18 - 75

Code: NCT07142291·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

SW-682 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Scottsdale +7 more locations

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All·Age: 18+

Code: NCT06251310·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

for Heart Failure

Sites in Scottsdale, Mesa +10 more locations

Sponsor: EBR Systems, Inc.

Sex: All·Age: 22+

Code: NCT07098858·Recruiting·Listed Aug 2025

Apply to this trial

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

for Chronic Kidney Disease (Stages 4 and 5)

Sites in Scottsdale & Phoenix

Sponsor: Well Cell Global

Sex: All·Age: 18+

Code: NCT07187479·Recruiting·Listed Sep 2025

Apply to this trial

ORB-021 In Patients With Advanced Solid Tumors

for Advanced Solid Tumors Cancer

Sites in Scottsdale +1 more location

Sponsor: Orionis Biosciences Inc

Sex: All·Age: 18+

Code: NCT06607939·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Scottsdale +4 more locations

Sponsor: Sun Pharma Advanced Research Company Limited

Sex: All·Age: 18+

Code: NCT07042100·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for Squamous Non-small-cell Lung Cancer

Sites in Scottsdale +7 more locations

Sponsor: Alentis Therapeutics AG

Sex: All·Age: 18+

Code: NCT06747585·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

for Advanced Metastatic Castration Resistant Prostate Cancer

Sites in Scottsdale +6 more locations

Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: Male·Age: 18+

Code: NCT06609005·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

for Rheumatoid Arthritis

Sites in Scottsdale +8 more locations

Sponsor: Sonoma Biotherapeutics, Inc.

Sex: All·Age: 18 - 70

Code: NCT06201416·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

for Recurrent Glioblastoma

Sites in Scottsdale +2 more locations

Sponsor: Alpha Tau Medical LTD.

Sex: All·Age: 18 - 85

Code: NCT06910306·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Scottsdale +3 more locations

Sponsor: Peel Therapeutics Inc

Sex: All·Age: 18+

Code: NCT05329103·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

1 location in Scottsdale

Sponsor: Domain Therapeutics Australia Pty Ltd

Sex: All·Age: 18+

Code: NCT06819735·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial